Geneva, 6 October 2021 – The RBM Partnership to End Malaria welcomes today’s historic recommendation by the World Health Organization (WHO) to scale up deployment of the first-ever malaria vaccine as a complementary prevention tool for children under 5 in sub-Saharan Africa and other regions with moderate to high P....Read more.
Roll Back Malaria
RBM Partnership Board thanks outgoing and welcomes new Board Members
At its 19th Board Meeting, the RBM Partnership to End Malaria Board voted in four new Members:
- Dr John Chimumbwa, Executive Director, Southern Africa Development Community (SADC) Malaria Elimination 8, Zambia
- Dr Helen Jamet, Deputy Director, Vector Control,...
RBM Partnership to End Malaria Board calls for nominations
Geneva, 24 September 2021 - In line with the RBM Board Rotation Policy...
RBM Partnership welcomes new commitments to malaria innovation, including mRNA platform and local manufacturing for malaria vaccine
Geneva, 26 July 2021 -- The RBM Partnership to End Malaria welcomes the announcement today of a major project by kENUP Foundation and BioNTech to develop the first mRNA-based prophylactic malaria vaccine.
Supported by the World Health Organization (...